Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Dose Optimization of Pembrolizumab: Less May Be More.
Promising new agents in oncologic treatment.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Promising new agents in oncologic treatment.
Promising new agents in oncologic treatment. Curr Opin Oncol. 1996 Nov; 8(6):525-34.
View in:
PubMed
subject areas
Animals
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Camptothecin
Clinical Trials, Phase II as Topic
Deoxycytidine
Drug Design
Drug Screening Assays, Antitumor
Enzyme Inhibitors
Humans
Mice
Microtubules
Neoplasm Proteins
Neoplasms
Paclitaxel
Thymidylate Synthase
Topoisomerase I Inhibitors
Topotecan
authors with profiles
Mark J. Ratain